Jyong Biotech Delays Annual 20-F (Yearly Report)
Jyong Biotech Ltd. ( ($MENS) ) has released a notification of late filing. Jyong Biotech Ltd. has filed a Form 12b-25, notifying investors of a delay in submitting its Form
6M agoMENS
Compare Stocks
Compare up to 40 stocks
Compared Stocks: 1 / 40
Comparison Results
| Name | Sector | Price | Volume | Market Cap | P/E Ratio | Dividend Yield | Analyst Consensus | Analyst Price Target | Smart Score | Leveraged ETF | Article | Follow |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
 MENS | General | $1.76 | 27.03K | $129.17M | -19.54 | ― | ― |
Top 10 Popular Investment Themes
- Quantum Computing Stocks
- Dividend Stocks
- Magnificent 7 Stocks
- Nuclear Stocks
- Oil Stocks
- Tech Stocks
- Blue Chip Stocks
- Energy Stocks
- Bank Stocks
- Gold Stocks
Popular Stock Pairs
- AAPL vs. MSFT (Apple vs. Microsoft)
- AAPL vs. NVDA (Apple vs. Nvidia)
- AMD vs. INTC (AMD vs. Intel)
- AMZN vs. GOOGL
- AMZN vs. WMT (Amazon vs. Walmart)
- AVGO vs. QCOM (Broadcom vs. Qualcomm)
- COST vs. WMT (Costco vs. Walmart)
- F vs. GM (Ford vs. General Motors)
- GOOGL vs. META (Alphabet vs. Meta)
- HD vs. LOW (Home Depot vs. Lowe's)
- JPM vs. BAC (JPMorgan vs. Bank of America)
- KO vs. PEP (Coca-Cola vs. PepsiCo
- MSFT vs. GOOGL vs. AMZN (Cloud Wars)
- NVDA vs. AMD vs. INTC (Chip Giants)
- NVDA vs. TSM (Nvidia vs. Taiwan Semi)
Performance Comparison
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| MENS | Jyong Biotech Ltd. | 1.76 | -38.25 | -95.60% |
| Name | Price | % Change | |
|---|---|---|---|
| MENS | $1.76 | -95.60% |
Custom Stock Latest News
Jyong issues strategic corporate update, completes Phase II trial for MCS-8Jyong Biotech (MENS) issued a strategic corporate update. This review encapsulates a pivotal period characterized by the successful completion of the Phase II clinical trial for its lead candidate, MCS-8,
9M agoMENS
Jyong Biotech Appoints Veteran Capital Markets Executive Wei Zhang as Chief Financial OfficerJyong Biotech Ltd. ( ($MENS) ) has issued an update. On February 6, 2026, Jyong Biotech Ltd. announced the appointment of Wei (Vivi) Zhang as its new Chief Financial Officer,
Jyong Biotech subsidiary announces phase II data for MCS-8Jyong Biotech (MENS) announced updated statistical analyses for key blood biochemical markers from its Phase II clinical trial of MCS-8 conducted in Taiwan. The results underscore MCS-8’s previously indicated multifaceted
9M agoMENS
Ten new option listings and two option delistings on January 22ndNew option listings for January 22nd include Aardvark Therapeutics Inc (AARD), Anteris Technologies Global Corp (AVR), Climb Bio Inc (CLYM), REX Drone ETF (DRNZ), Grace Therapeutics, Inc (GRCE), Infinity Natural
Jyong Biotech Reports Higher Assets but Deeper Shareholders’ Deficit in June 2025 Unaudited ResultsThe latest update is out from Jyong Biotech Ltd. ( ($MENS) ). On January 9, 2026, Jyong Biotech Ltd. furnished unaudited interim condensed consolidated financial statements for the six months
Jyong Biotech ‘not aware’ of any material information amid share price movementJyong Biotech (MENS) noted the recent fluctuation in its share price and the increased trading volume of its shares on the Nasdaq Stock Exchange following the expiry of the lock-up
10M agoMENS
Jyong Biotech Ltd trading resumes11:25 EST Jyong Biotech (MENS) Ltd trading resumes Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today’s best-performing stocks on TipRanks
11M agoMENS
Jyong Biotech Ltd trading halted, volatility trading pause11:15 EST Jyong Biotech (MENS) Ltd trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today’s best-performing
11M agoMENS
Jyong Biotech signs MOU with Vietnam pharmaceutical distributorJyong Biotech (MENS) announced that it has entered into a non-binding Memorandum of Understanding, MOU, with a Vietnam-based pharmaceutical distribution company headquartered in Ho Chi Minh City, to evaluate the
11M agoMENS
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
- Comprehensive Analysis: Compare up to 40 stocks with detailed metrics including price, market cap, P/E ratio, dividend yield, and more.
- Analyst Ratings: View consensus ratings from top Wall Street analysts and their price targets for each stock.
- Performance Tracking: Analyze historical performance with interactive charts showing 3-month, 6-month, 1-year, YTD, 3-year, and 5-year returns.
- Dividend Information: Evaluate dividend yield, payout ratio, and dividend growth for income-focused investors.
- Earnings Data: Compare earnings per share (EPS), revenue growth, and profitability metrics across companies.
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.
All Stock Comparison Categories
- AAPL vs. MSFT (Apple vs. Microsoft)
- AMZN vs. GOOGL
- GOOGL vs. META (Alphabet vs. Meta)
- AAPL vs. NVDA (Apple vs. Nvidia)
- AMZN vs. WMT (Amazon vs. Walmart)
- AMD vs. INTC (AMD vs. Intel)
- AVGO vs. QCOM (Broadcom vs. Qualcomm)
- NVDA vs. TSM (Nvidia vs. Taiwan Semi)
- TSLA vs. RIVN (Tesla vs. Rivian)
- F vs. GM (Ford vs. General Motors)
- TSLA vs. LCID (Tesla vs. Lucid)
- V vs. MA (Visa vs. Mastercard)
- JPM vs. BAC (JPMorgan vs. Bank of America)
- PYPL vs. XYZ (PayPal vs. Block)
- HD vs. LOW (Home Depot vs. Lowe's)
- KO vs. PEP (Coca-Cola vs. PepsiCo
- COST vs. WMT (Costco vs. Walmart)
- NVDA vs. AMD vs. INTC (Chip Giants)
- MSFT vs. GOOGL vs. AMZN (Cloud Wars)
- TSLA vs. F vs. GM (Auto Wars)
- V vs. MA vs. AXP (Credit Cards)
- Quantum Computing Stocks
- Dividend Stocks
- Magnificent 7 Stocks
- Nuclear Stocks
- Oil Stocks
- Tech Stocks
- Blue Chip Stocks
- Energy Stocks
- Bank Stocks
- Gold Stocks
- Growth Stocks
- Bitcoin Stocks
- Meme Stocks
- Biotech Stocks
- Chinese Stocks
- Artificial Intelligence Stocks
- Cannabis Stocks
- Healthcare Stocks
- Value Stocks
- Airline Stocks
- Cybersecurity Stocks
- OpenAI Stocks
- Solar Stocks
- ChatGPT Stocks
- FAANG Stocks
- Green Energy Stocks
- Large Cap Stocks
- Utility Stocks
- Chip Stocks
- Blockchain Stocks
- Social Media Stocks
- Cryptocurrency Stocks
- Electric Vehicle Stocks
- Japanese Stocks
- Casino Stocks
- Metaverse Stocks
- Highest PE Ratio Stocks
- Mega Cap Stocks
- Hotel Stocks
- Green Hydrogen Stocks
- 5g Stocks
- Aerospace and Defense Stocks
- Batmmaan Stocks
- WallStreetBets Stocks
- Virtual Reality Stocks
- Cloud & Storage Stocks
- Lowest P/E Ratio Stocks
- Adtech Stocks
- Biotech & Longevity Plays
- Nuclear Energy Revival Stock
- Onshoring & Rare Earths Supply Stocks
- Popular BDC Stocks
- Private Credit & Fintech Risers
- Quantum Computing Innovators Stocks
- Robotics & Autonomous Systems Stocks
- Beer & Beverage Stocks
- International Value Diversifiers Stocks
- AI Data Center Pivot Miners
- AI Data Center Power Stocks
- Big Oil SAF Refiners (Biofuels)
- Data Center & AI Infrastructure Stocks
- MSFT vs. META (Microsoft vs. Meta)
- Popular South Korean Stocks
- Situational Awareness Q1 Pivot
- Situational Awareness Solar & Battery Bets
- Situational Awareness Top 10 Holdings
- Sustainable Aviation Fuel (SAF) Pure-Plays
- Top Robotics Stocks (Medical, AI & Industrial)
- Top Silver Stocks
- Trump Tariff Risk Stocks (Retail & Tech)
- Trump Tariff Winners (Steel, Manufacturing & Auto)
- Venezuela Oil Recovery (Energy & Services)
- Venezuela Seized Assets (Consumer/Industrial)
Custom Stock - FAQ
Which Custom stocks have a "Strong Buy" analyst rating?
None of the selected stocks have a “Strong Buy” analyst rating consensus.
Are Custom stocks overpriced?
Jyong Biotech Ltd.'s stock price is currently $1.76, and its average 12-month price target is N/A.
Which Custom stocks pay dividends?
Jyong Biotech Ltd. does not currently pay dividends.